| AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |
| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| ARR3 |
P36575
|
arrestin 3
|
Enzyme modulator
|
0.10 |
0.460 |
0.846 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
| CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
| CASR |
P41180
|
calcium sensing receptor
|
G-protein coupled receptor
|
4.7E-02 |
0.410 |
0.846 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CD200 |
P41217
|
CD200 molecule
|
|
0.41 |
0.529 |
0.769 |
| CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| CIB1 |
Q99828
|
calcium and integrin binding 1
|
|
3.3E-04 |
0.458 |
0.769 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
| CXCR3 |
P49682
|
C-X-C motif chemokine receptor 3
|
G-protein coupled receptor
|
0.18 |
0.436 |
0.808 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| CXCR5 |
P32302
|
C-X-C motif chemokine receptor 5
|
G-protein coupled receptor
|
0.73 |
0.524 |
0.769 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| FCER2 |
P06734
|
Fc fragment of IgE receptor II
|
Receptor
|
7.6E-12 |
0.560 |
0.654 |
| FCRL1 |
Q96LA6
|
Fc receptor like 1
|
Cell adhesion
|
4.0E-06 |
0.751 |
0.308 |